Chemoinformaics analysis of (+)-Cis,Trans-Abscisic Acid
Molecular Weight | 264.321 | nRot | 3 |
Heavy Atom Molecular Weight | 244.161 | nRig | 10 |
Exact Molecular Weight | 264.136 | nRing | 1 |
Solubility: LogS | -2.465 | nHRing | 0 |
Solubility: LogP | 2.342 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 41.5939 |
nHD | 2 | BPOL | 21.8001 |
QED | 0.605 |
Synth | 3.792 |
Natural Product Likeliness | 2.722 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.026 |
HIA | 0.021 |
CACO-2 | -5.187 |
MDCK | 0.0000248 |
BBB | 0.572 |
PPB | 0.79896 |
VDSS | 0.343 |
FU | 0.0919085 |
CYP1A2-inh | 0.012 |
CYP1A2-sub | 0.334 |
CYP2c19-inh | 0.048 |
CYP2c19-sub | 0.087 |
CYP2c9-inh | 0.355 |
CYP2c9-sub | 0.613 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.133 |
CYP3a4-inh | 0.016 |
CYP3a4-sub | 0.27 |
CL | 1.678 |
T12 | 0.881 |
hERG | 0.016 |
Ames | 0.012 |
ROA | 0.691 |
SkinSen | 0.945 |
Carcinogencity | 0.375 |
EI | 0.142 |
Respiratory | 0.811 |
NR-Aromatase | 0.424 |
Antiviral | Yes |
Prediction | 0.845488 |